Top entities: Pakistan, Pakistan — Drug Regulatory Authority of Pakistan, Mustafa Kamal.

What category does this event fall under?

Regulatory — classified as regulatory approval.

What is the sentiment of coverage?

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This event is archived — the story has concluded and this page is a final snapshot.

Regulatory regulatory approval

Pakistan approves medicine Track and Trace

Q: When did this event occur?

First reported Jun 02, 2026; last updated Jun 02, 2026.

Q: What is the market impact?

General. The approval of the Track and Trace system in Pakistan is expected to positively impact the pharmaceutical sector by reducing counterfeit medicines, thereby increasing consumer trust and potentially boosting sales for legitimate manufacturers.

Analysis based on 12 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The approval of the Track and Trace system in Pakistan is expected to positively impact the pharmaceutical sector by reducing counterfeit medicines, thereby increasing consumer trust and potentially boosting sales for legitimate manufacturers. This regulatory advancement could also attract foreign investment into Pakistan's pharmaceutical industry.

Pharmaceuticals Healthcare Technology

Event Summary

The federal cabinet of Pakistan has approved the nationwide implementation of a Track and Trace system for pharmaceutical products, alongside necessary amendments to the Drug Labeling and Packing Rules 1978. This initiative, announced by Federal Health Minister Mustafa Kamal, aims to combat counterfeit, fake, and substandard medicines by enabling digital traceability and verification of every medicine from production to consumption. All pharmaceutical manufacturers and importers in Pakistan will be required to place standardized 2D barcodes and serialization data on medicine packaging. The Pakistan — Drug Regulatory Authority of Pakistan (DRAP) will oversee the rollout, issue technical guidelines, and ensure compliance, positioning Pakistan as a regional leader in pharmaceutical regulation and enhancing public trust in the healthcare sector.

Entities Involved

cnt

Pakistan

The implementation of the Track and Trace system is expected to significantly improve public health and the integrity of the pharmaceutical supply chain within Pakistan, positioning it as a regional leader in pharmaceutical regulation.

Importance 100.0 Sentiment 70.0

govactor

Pakistan — Drug Regulatory Authority of Pakistan

The Pakistan — Drug Regulatory Authority of Pakistan (DRAP) is responsible for overseeing the nationwide rollout and implementation of the Track and Trace system, ensuring compliance from the pharmaceutical industry.

Importance 90.0 Sentiment 60.0

per

Mustafa Kamal

As the Federal Minister for Health, Mustafa Kamal announced and championed the approval and implementation of the Track and Trace system, highlighting its importance for public health and market transparency.

Importance 80.0 Sentiment 60.0

Relationships

Pakistan related ↔ Pakistan — Drug Regulatory Authority of Pakistan

Pakistan related ↔ Mustafa Kamal

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard